Genomic Health, Inc.
GHDX
GHDX was delisted on the 7th of November, 2019.
111 hedge funds and large institutions have $824M invested in Genomic Health, Inc. in 2013 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 39 increasing their positions, 38 reducing their positions, and 8 closing their positions.
3% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 38
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less capital invested
Capital invested by funds: $858M → $824M (-$33.9M)
3% less funds holding
Funds holding: 115 → 111 (-4)
19% less call options, than puts
Call options by funds: $992K | Put options by funds: $1.23M
25% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$10M |
| 2 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$3.72M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$3.55M |
| 4 |
Wells Fargo
San Francisco,
California
|
+$2.24M |
| 5 |
CCMH
Cornerstone Capital Management Holdings
New York
|
+$1.31M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FWIA
Fort Washington Investment Advisors
Cincinnati,
Ohio
|
-$5.3M |
| 2 |
Renaissance Technologies
New York
|
-$4.32M |
| 3 |
ICM
IronBridge Capital Management
Oakbrook Terrace,
Illinois
|
-$3.3M |
| 4 |
Two Sigma Investments
New York
|
-$2.85M |
| 5 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$2.29M |
GHDX Hedge Fund Activity: Q3 2013 in Review
111 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Genomic Health, Inc. (GHDX) for Q3 2013, worth a combined $824M — down 3.9% from $858M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of GHDX and 6 opened new positions — a net loss of 2 holders — while 38 trimmed existing stakes and 39 added.
The largest buyer was Baillie Gifford & Co, adding an estimated $10M. The largest seller was Fort Washington Investment Advisors, cutting an estimated $5.3M.
- 111 institutional investors held Genomic Health, Inc. (GHDX) as of Q3 2013, down from 115 in Q2 2013.
- Funds reported $824M of Genomic Health, Inc. stock for Q3 2013, down 3.9% quarter-over-quarter.
- 6 funds opened new Genomic Health, Inc. positions in Q3 2013 and 8 closed out, a net change of -2 holders.
- The largest Genomic Health, Inc. buyer in Q3 2013 was Baillie Gifford & Co, an estimated $10M added.
- The largest Genomic Health, Inc. seller in Q3 2013 was Fort Washington Investment Advisors, an estimated $5.3M sold.
Based on aggregated 13F filings for Q3 2013.